Explore our premier hospital-grade diagnostic support, personal protective equipment, and infection control supply lines crafted for global clinical compliance.
China has established itself as the world’s hub for high-volume, highly precise In-Vitro Diagnostic (IVD) manufacturing. The integration of advanced colloidal gold immunoassay technology, microfluidics, and automated high-throughput assembly lines enables leading Chinese suppliers to provide international distributors, healthcare systems, and consumer brands with unmatched quality-to-cost efficiency.
Within this ecosystem, sourcing medical testing kits and clinical consumables requires partnering with manufacturers that not only deliver micro-analytical precision but also adhere to stringent bio-safety protocols, sterile environment packaging, and international regulatory frameworks (CE IVDR, US FDA 510(k), and ISO standards).
The core mechanism of rapid human Chorionic Gonadotropin (hCG) and Luteinizing Hormone (LH) detection relies on double-antibody sandwich lateral flow immunoassay technology. When a liquid specimen (urine or serum) is applied to the sample pad, it migrates via capillary action through the conjugate pad containing monoclonal anti-hCG/LH antibodies conjugated with colloidal gold nanoparticles.
If target hormone concentrations meet or exceed the analytical threshold (e.g., 10 mIU/mL or 25 mIU/mL), the antigen-antibody-gold complex binds to secondary immobilized antibodies on the Test Line (T-Line), causing a visible chromatic band. Unbound conjugate continues migrating to the Control Line (C-Line) to validate procedural integrity.
Follicle-Stimulating Hormone (FSH) rapid test kits utilize calibrated cut-off values (typically 25 mIU/mL to 40 mIU/mL) to assist clinicians and patients in screening for perimenopause, ovarian failure, or pituitary disfunction. High specificity monoclonal antibodies prevent cross-reactivity with structurally similar glycoprotein hormones such as Thyroid-Stimulating Hormone (TSH) and Human Chorionic Gonadotropin (hCG).
Next-generation fertility testing is shifting from qualitative visual interpretation to quantitative digital analysis. Utilizing reader-compatible fluorescent latex beads or quantum dot markers, Chinese OEM facilities manufacture high-precision lateral flow test strips that interface with optical handheld meters, allowing tracking of quantitative LH surge slopes, baseline estrogen (E13G) levels, and progesterone (PdG) metabolites.
Hangzhou Ultrivex Medical Co., Ltd. is a professional Medical Disposable Protective Products Manufacturer dedicated to delivering reliable infection control solutions and healthcare safety equipment to global markets. Based in Hangzhou, China, the company specializes in the development, production, and supply of a wide range of disposable medical protective products designed for hospitals, laboratories, cleanrooms, and industrial hygiene environments.
Ultrivex Medical focuses on high-quality nonwoven materials and advanced manufacturing processes to ensure consistent product performance, safety, and comfort. Its product portfolio includes protective apparel, patient care disposables, and hygiene solutions that meet the evolving demands of infection prevention and control. All products are manufactured under strict quality management systems and comply with international standards to support safe and efficient medical operations.
With a strong commitment to innovation and customer satisfaction, Ultrivex provides flexible OEM and ODM services tailored to distributors, healthcare institutions, and medical brands worldwide. The company continuously invests in technology upgrades and process optimization to enhance production efficiency and product reliability.
Driven by the mission to safeguard health and improve hygiene standards, Hangzhou Ultrivex Medical Co., Ltd. strives to be a trusted global partner in medical disposable protection and healthcare safety solutions.








| Assay Type | Target Biomarker | Detection Limit (Sensitivity) | Analytical Precision | Form Factor / Format | Primary Target Application |
|---|---|---|---|---|---|
| Early Detection Pregnancy | hCG (human Chorionic Gonadotropin) | 10 mIU/mL – 25 mIU/mL | > 99.2% Accuracy | Strip, Cassette, Midstream | OTC Consumer & Clinical Triage |
| Ovulation Predictor (LH Surge) | LH (Luteinizing Hormone) | 20 mIU/mL – 40 mIU/mL | > 99.0% Correlation | Strip, Digital Midstream | Fertility Tracking & Conception Support |
| Ovarian Reserve / Menopause | FSH (Follicle Stimulating Hormone) | 25 mIU/mL | > 98.8% Specificity | Cassette, Midstream | Endocrine Assessment & Menopause Care |
| Luteal Phase Evaluation | PdG (Pregnanediol-3-Glucuronide) | 5 ug/mL | > 97.5% Specificity | Lateral Flow Strip | Confirming Ovulation Success |
| Male Fertility Screening | SP10 Protein / Sperm Density | 15 Million/mL Threshold | > 96.5% Correlation | Well-Cassette System | At-Home Male Reproductive Health |
Integration of machine-vision algorithms capable of analyzing colorimetric density on lateral flow lines via mobile phone cameras. Eliminates user interpretation error and quantifies hormone trends.
Simultaneous multi-parameter testing strips capable of assaying LH, FSH, hCG, and E13G on a single microfluidic cassette, offering a holistic view of the menstrual cycle in one step.
Transitioning from traditional ABS plastics to biodegradable polymers, recyclable housing designs, and eco-friendly nonwoven backing materials to reduce global medical plastic waste.
Expanded solutions in medical protective barriers, patient transfer underpads, surgical drapes, and specialized cleanroom textiles.